| Similar Articles |
|---|
 |
The Motley Fool
February 1, 2006
Rich Smith |
Foolish Forecast: Clorox Comes Clean Over the past four quarters, Clorox's rolling margin results have fallen consecutively in the gross, operating, and net categories. Investors, take note.   |
The Motley Fool
May 6, 2005
Stephen D. Simpson |
Clorox Gets Bleached Out High commodity prices have stolen away growth and cash flow. |
The Motley Fool
May 2, 2008
Matthew Reilly |
The Market's Got the Magic of Clorox Bleach Clorox shares rally after the company shrugs off pessimists. |
The Motley Fool
May 4, 2010
Mike Pienciak |
Can Clorox Brighten Your Portfolio? The market's lingering disappointment here could spell opportunity. |
The Motley Fool
February 7, 2005
Stephen D. Simpson |
Bright, But Not Bold, Clorox Steady but unspectacular growth might leave investors wanting a bit more kick. |
The Motley Fool
February 7, 2011
Matt Koppenheffer |
A Messy Quarter for This Bleach Baron It wasn't a pretty quarter for Clorox, but the future may look a bit brighter. |
The Motley Fool
April 27, 2006
Steven Mallas |
Colgate's Cool Quarter Colgate-Palmolive didn't have a spectacular quarter, but it's still a good investment idea. |
The Motley Fool
October 7, 2010
Seth Jayson |
From Gross to Net at Procter & Gamble Here's the margin picture for Procter & Gamble over the past few years. |
The Motley Fool
November 7, 2005
Jeremy MacNealy |
Can Clorox Remove This Stain? Clorox is a solid company in many ways, but it competes with consumer goods rivals and struggles with increased energy-related costs. Investors, take note. |
The Motley Fool
June 16, 2009
Mike Pienciak |
Earn a Tidy Profit With Clorox Clorox's consumer reach extends to popular car-care products, cat litter, and that money-saving water pitcher in your fridge -- Brita. Its brands are market-share leaders in seven of the nine largest categories in which it competes. |
The Motley Fool
May 20, 2005
Steven Mallas |
Clorox: A Fresh Idea? Clorox has a nice history of long-term performance -- but should you buy it now? |
The Motley Fool
September 28, 2011
Tamara Rutter |
A Recession-Proof Stock for Your Portfolio Is Procter & Gamble is a winning bet in a losing market? |
The Motley Fool
August 4, 2010
Matt Koppenheffer |
Clorox? More Like Snore-ox! Clorox announces its fiscal fourth-quarter and full-year earnings. |
The Motley Fool
October 24, 2011 |
A Brief History of Clorox's Returns Clorox shares returned 145% over the past decade. How'd they get there? |
The Motley Fool
June 7, 2010
Jim Royal |
Colgate-Palmolive Can Always Outperform Colgate-Palmolive offers the ability to outperform peers such as Procter & Gamble and Clorox because of one special quirk of consumers. |
The Motley Fool
August 11, 2010
Seth Jayson |
Marginal Performance at PepsiCo With recent 12-month-period operating margins below historical averages, PepsiCo has some work to do. |
The Motley Fool
February 9, 2010
Mike Pienciak |
Clorox: A Dull Gleam, or Just Plain Dull? The company's recent results send mixed signals. |
The Motley Fool
August 22, 2011
Jeff Bailey |
Fending Off Icahn, Clorox Takes It Out on Consumers With Big Price Hikes Does Clorox still look like a bargain? |
The Motley Fool
January 12, 2011
Andrew Bond |
This Stock Is a Lot Sexier Than You Think While Clorox's products bore many, its returns are more exciting. |
The Motley Fool
August 8, 2011
Matt Koppenheffer |
Procter & Gamble: A Rock-Solid Refuge Procter & Gamble still looks like a good choice after its fiscal fourth-quarter earnings. |
The Motley Fool
May 3, 2007
Steven Mallas |
Bleach: An Exciting Investment Thesis? Clorox had a bright third quarter. Investors, take note. |
The Motley Fool
September 3, 2010
Matt Koppenheffer |
How Much Is Clorox Worth? Clorox is a stable company with a portfolio of strong brands, opportunity to grow both domestically and internationally, and its stock may be on sale right now. |
The Motley Fool
December 11, 2010
Jeremy Phillips |
Time to Sell PepsiCo? Over the past 12 months, PepsiCo has risen by 2.1% versus an S&P 500 return of 11.3%. Investors are perhaps disappointed with their returns, but is now the time to cut and run? Not necessarily. |
The Motley Fool
November 3, 2009
Mike Pienciak |
This Stable Stock Could Still Surprise Clorox shares have so far been passed over by the market rally. |
The Motley Fool
May 2, 2007 |
P&G Flies at Mach 3: Fool by Numbers The conglomerate released third-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
January 24, 2006
Rich Smith |
Foolish Forecast: Colgate-Palmolive in the Wash Will the stock's winning streak continue? Wednesday's fourth-quarter and full-year 2005 results could factor heavily in answering that question. |
The Motley Fool
December 19, 2005
Seth Jayson |
Clorox Brightens Forecast Clorox's guidance is a bit better. That may be enough to make the shares cheap. Investors on the lookout for a premium company at a bargain price may not have to wait much longer. |
The Motley Fool
April 6, 2006
Steven Mallas |
WD-40: Of Margins and Dividends The company has done well with earnings and cash flow, but considering its declining margins and dividend history, investors may not be inclined to put money to work here. |
The Motley Fool
June 29, 2011
Eric Bleeker |
Procter & Gamble: Assessing the International Opportunity Where's Procter & Gamble generating its sales? |
The Motley Fool
August 22, 2011
Dan Radovsky |
Should Icahn's Interest in Clorox Perk Yours? Does corporate raider Carl Icahn want to clean Clorox's house for himself, or does he just want to flip it for a quick profit? |
The Motley Fool
August 10, 2010
Seth Jayson |
Marginal Performance at Apple I'm looking for the absolute numbers, comparisons to sector peers and competitors, and any trend that may tell me how strong Apple's competitive position could be. |
The Motley Fool
July 18, 2011
Rich Smith |
Carl Icahn's Clorox Pipedream Icahn announced that he wants to up his 9.4% stake in Clorox, bidding to buy the whole company for $76.50 per share. |
The Motley Fool
October 29, 2009
Mike Pienciak |
Making a Mint in the Recession Colgate-Palmolive delivers record profits. |
The Motley Fool
August 11, 2010
Seth Jayson |
Marginal Performance at Amazon.com Here's the current margin snapshot for Amazon.com and some of its sector and industry peers, and direct competitors. |
The Motley Fool
August 19, 2010
Seth Jayson |
Where Is American Public Education's Bottom Line Headed? Here's the current margin snapshot for American Public Education and some of its sector and industry peers, and direct competitors. |
The Motley Fool
November 19, 2010
Seth Jayson |
Where's the Cash Coming From at Clorox? With questionable cash flows amounting to only 3.9% of operating cash flow, Clorox's cash flows look clean. |
The Motley Fool
August 11, 2010
Seth Jayson |
Marginal Performance at Akamai Technologies The more Akamai Technologies keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans |
The Motley Fool
February 2, 2007
Steven Mallas |
Clorox Cleans Up on Wall Street Clorox comes clean with its second-quarter numbers. Investors, this is a good candidate for a dollar-cost-averaging strategy within the environment of a long-term portfolio. |
The Motley Fool
August 11, 2010
Seth Jayson |
Marginal Performance at Peabody Energy The more Peabody Energy keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans |
The Motley Fool
August 11, 2010
Seth Jayson |
Marginal Performance at Apache With recent 12-month-period operating margins below historical averages, Apache has some work to do. There may be some hope in the last quarter's results, but only time will tell. |
The Motley Fool
August 31, 2006 |
Foolish Fundamentals: Margins Margins are important, but how you use margin information is more important to your investing success. Don't stay on the surface when analyzing margins. Your portfolio will thank you for it later. |
The Motley Fool
September 14, 2010
Seth Jayson |
Will Clorox Blow It Next Quarter? Is Clorox sending any warning signs? Take a look at this chart, which plots revenue growth against accounts receivable growth and days sales outstanding. |
The Motley Fool
October 4, 2005
Stephen D. Simpson |
The Gray Picture for Clorox Higher expenses are going to start hurting profits, while higher prices might curtail growth. As for the stock, it's not looking too expensive relative to past levels. But it's not a screaming bargain, either. |
The Motley Fool
October 1, 2009
Mike Pienciak |
2 Big Reasons to Love Colgate-Palmolive The bullish argument about Colgate-Palmolive is that it boasts superior margins and a resilient product portfolio. |
The Motley Fool
November 17, 2011 |
A Brief History of Colgate-Palmolive's Returns Despite constant attempts by analysts and the media to complicate the basics of investing, there are really only three ways a stock can create value for its shareholders. |
The Motley Fool
June 17, 2004
Steven Mallas |
Clorox's Bright-White Guidance Clorox not only supplies products that keep your clothes clean and fresh but it can also deliver some crisp earnings as well. |
The Motley Fool
January 17, 2012
Matt Koppenheffer |
What's Ahead for Procter & Gamble in 2012? Procter & Gamble is a dividend stalwart and an investor favorite. But what can investors expect next? |
The Motley Fool
January 11, 2012 |
What Clorox Does With Its Cash Over the last five years, Clorox shares have returned 24%, which drops to 7% without dividends -- not a bad boost to top off otherwise low share performance. |
The Motley Fool
June 19, 2011
Jordan DiPietro |
Should You Retire With Procter & Gamble? Procter & Gamble has a beta of 0.4, which is pretty low. Generally speaking, I like to see a beta below 1.2 for retirees, and Procter & Gamble fits the bill. |
The Motley Fool
February 25, 2010
Alex Dumortier |
20 Billion Reasons Not to Invest on Wall Street Securities firms are not run for the benefit of outside shareholders; they are run for the benefit of "inside" shareholders (i.e., the employee-shareholders), who accrue a disproportionate amount of the wealth these firms create. |
